虫草素在骨质疏松症中的骨保护作用
The Bone-Protective Effect of Cordycepin in Osteoporosis
摘要: 骨质疏松是绝经后的妇女和老年人面临的一个主要临床问题,其本质在于骨重塑(bone remodeling)失衡,即成骨细胞(osteoblast)介导的骨形成与破骨细胞(osteoclast)介导的骨吸收之间的动态平衡被打破,导致骨骼脆性增加,发生骨折的概率升高,这会造成身体残疾、医疗费用升高、生活质量受损等后果。目前研究发现炎症、氧化应激、骨稳态失衡等因素会严重影响骨骼的生理功能,从而引发骨质疏松等骨类疾病。因此,找到合适的药物对骨类疾病进行预防和修复尤为重要。虫草素是从蛹虫草内提取出来的活性物质,具有抗炎、抗氧化、改善代谢紊乱等多个功能,并且有多项研究发现虫草素对骨具有明显的修复作用。因此,本篇综述对虫草素在骨质疏松症中的骨保护作用进行梳理,从抗炎、抗氧化、调节骨稳态和骨源细胞因子多个方面进行论述,为治疗骨类药物的研制和开发提供更多的理论依据。
Abstract: Osteoporosis is a major clinical issue faced by postmenopausal women and the elderly. Its essence lies in the imbalance of bone remodeling, where the dynamic equilibrium between osteoblast-mediated bone formation and osteoclast-mediated bone resorption is disrupted. It leads to increased skeletal fragility and a higher likelihood of fractures, resulting in disability, higher medical costs, and a reduced quality of life. Recent studies have found that factors such as inflammation, oxidative stress, and imbalance of bone homeostasis significantly impact bone physiology, contributing to the onset of bone diseases like osteoporosis. Therefore, it is crucial to identify suitable drugs for the prevention and repair of bone diseases. Cordycepin, an active substance extracted from Cordyceps sinensis, has anti-inflammatory, antioxidant, and metabolic regulatory properties. Several studies have shown that cordycepin exerts significant bone-repairing effects. This review examines the bone-protective effects of cordycepin in osteoporosis, focusing on its mechanisms involving anti-inflammation, antioxidant activity, modulation of bone homeostasis, and bone-derived cytokines, providing a theoretical foundation for the development and design of therapeutic agents for bone diseases.
文章引用:张俊颖, 暴金来, 郑慧娴, 林虹杉, 刘美彤, 于洪友. 虫草素在骨质疏松症中的骨保护作用[J]. 临床医学进展, 2025, 15(9): 240-245. https://doi.org/10.12677/acm.2025.1592481

参考文献

[1] Johnston, C.B. and Dagar, M. (2020) Osteoporosis in Older Adults. Medical Clinics of North America, 104, 873-884. [Google Scholar] [CrossRef] [PubMed]
[2] Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D.F., Carcelén-Fraile, M.D.C. and López-Ruiz, E. (2022) Current Status of the Diagnosis and Management of Osteoporosis. International Journal of Molecular Sciences, 23, Article 9465. [Google Scholar] [CrossRef] [PubMed]
[3] Vilaca, T., Eastell, R. and Schini, M. (2022) Osteoporosis in Men. The Lancet Diabetes & Endocrinology, 10, 273-283. [Google Scholar] [CrossRef] [PubMed]
[4] Iantomasi, T., Romagnoli, C., Palmini, G., Donati, S., Falsetti, I., Miglietta, F., et al. (2023) Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with MicroRNAs. International Journal of Molecular Sciences, 24, Article 3772. [Google Scholar] [CrossRef] [PubMed]
[5] Kim, J., Lee, H., Kang, K.S., Chun, K. and Hwang, G.S. (2015) cordyceps Militarismushroom and Cordycepin Inhibit Rankl-Induced Osteoclast Differentiation. Journal of Medicinal Food, 18, 446-452. [Google Scholar] [CrossRef] [PubMed]
[6] Zhang, D., Wang, Z., Qi, W., Lei, W. and Zhao, G. (2014) Cordycepin (3’-Deoxyadenosine) Down-Regulates the Proinflammatory Cytokines in Inflammation-Induced Osteoporosis Model. Inflammation, 37, 1044-1049. [Google Scholar] [CrossRef] [PubMed]
[7] Wang, F., Yin, P., Lu, Y., Zhou, Z., Jiang, C., Liu, Y., et al. (2015) Cordycepin Prevents Oxidative Stress-Induced Inhibition of Osteogenesis. Oncotarget, 6, 35496-35508. [Google Scholar] [CrossRef] [PubMed]
[8] Yang, L., Li, G., Chai, Z., Gong, Q. and Guo, J. (2020) Synthesis of Cordycepin: Current Scenario and Future Perspectives. Fungal Genetics and Biology, 143, Article ID: 103431. [Google Scholar] [CrossRef] [PubMed]
[9] Dou, C., Cao, Z., Ding, N., Hou, T., Luo, F., Kang, F., et al. (2016) Cordycepin Prevents Bone Loss through Inhibiting Osteoclastogenesis by Scavenging ROS Generation. Nutrients, 8, Article 231. [Google Scholar] [CrossRef] [PubMed]
[10] Yu, S., Kim, H., Kang, H., Park, B., Lee, J. and Kim, I. (2018) Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation in Vitro. Evidence-Based Complementary and Alternative Medicine, 2018, Article ID: 5892957. [Google Scholar] [CrossRef] [PubMed]
[11] Frommer, K.W., Neumann, E. and Lange, U. (2016) Entzündung und Knochen: Osteoimmunologische Aspekte. Zeitschrift für Rheumatologie, 75, 444-450. [Google Scholar] [CrossRef] [PubMed]
[12] Adami, G., Orsolini, G., Adami, S., Viapiana, O., Idolazzi, L., Gatti, D., et al. (2016) Effects of TNF Inhibitors on Parathyroid Hormone and WNT Signaling Antagonists in Rheumatoid Arthritis. Calcified Tissue International, 99, 360-364. [Google Scholar] [CrossRef] [PubMed]
[13] Radhi, M., Ashraf, S., Lawrence, S., Tranholm, A.A., Wellham, P.A.D., Hafeez, A., et al. (2021) A Systematic Review of the Biological Effects of Cordycepin. Molecules, 26, Article 5886. [Google Scholar] [CrossRef] [PubMed]
[14] Yang, J., Cao, Y., Lv, Z., Jiang, T., Wang, L. and Li, Z. (2015) Cordycepin Protected against the TNF-α-Induced Inhibition of Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. International Journal of Immunopathology and Pharmacology, 28, 296-307. [Google Scholar] [CrossRef] [PubMed]
[15] Chen, J., Qiu, M., Dou, C., Cao, Z. and Dong, S. (2015) MicroRNAs in Bone Balance and Osteoporosis. Drug Development Research, 76, 235-245. [Google Scholar] [CrossRef] [PubMed]
[16] Li, Z., Gu, Y., Lin, Z., Ma, H. and Zhang, S. (2020) Cordycepin Promotes Osteogenesis of Bone Marrow-Derived Mesenchymal Stem Cells and Accelerates Fracture Healing via Hypoxia in a Rat Model of Closed Femur Fracture. Biomedicine & Pharmacotherapy, 125, Article ID: 109991. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, Y., Zhu, D., Xu, Z., Yin, J., Yu, X., Mei, J., et al. (2017) The Protective Effect of Cordycepin on Alcohol-Induced Osteonecrosis of the Femoral Head. Cellular Physiology and Biochemistry, 42, 2391-2403. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, D., Deng, H., Qi, W., Zhao, G. and Cao, X. (2015) Osteoprotective Effect of Cordycepin on Estrogen Deficiency-Induced Osteoporosis in Vitro and in Vivo. BioMed Research International, 2015, Article ID: 423869. [Google Scholar] [CrossRef] [PubMed]
[19] Schröder, K. (2014) NADPH Oxidases in Bone Homeostasis and Osteoporosis. Cellular and Molecular Life Sciences, 72, 25-38. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, J., Xu, Y. and Shen, J. (2014) Cordycepin Inhibits Lipopolysaccharide (LPS)-Induced Tumor Necrosis Factor (TNF)-α Production via Activating Amp-Activated Protein Kinase (AMPK) Signaling. International Journal of Molecular Sciences, 15, 12119-12134. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, H., Zheng, X., Zhang, Y., Huang, J., Zhou, W., Li, X., et al. (2021) The Endocrine Role of Bone: Novel Functions of Bone-Derived Cytokines. Biochemical Pharmacology, 183, Article ID: 114308. [Google Scholar] [CrossRef] [PubMed]
[22] Rupp, T., Butscheidt, S., Vettorazzi, E., Oheim, R., Barvencik, F., Amling, M., et al. (2019) High FGF23 Levels Are Associated with Impaired Trabecular Bone Microarchitecture in Patients with Osteoporosis. Osteoporosis International, 30, 1655-1662. [Google Scholar] [CrossRef] [PubMed]
[23] Song, Z.H., Xie, W., Zhu, S.Y., Pan, J.J., Zhou, L.Y. and He, C.Q. (2018) Effects of PEMFs on Osx, Ocn, TRAP, and CTSK Gene Expression in Postmenopausal Osteoporosis Model Mice. International Journal of Clinical and Experimental Pathology, 11, 1784-1790.
[24] Williams, C. and Sapra, A. (2023) Osteoporosis Markers. StatPearls.
[25] Patil, S., Reda, R., Boreak, N., Taher, H.A., Melha, A.A., Albrakati, A., et al. (2021) Adipogenic Stimulation and Pyrrolidine Dithiocarbamate Induced Osteogenic Inhibition of Dental Pulp Stem Cells Is Countered by Cordycepin. Journal of Personalized Medicine, 11, Article 915. [Google Scholar] [CrossRef] [PubMed]
[26] McClung, M.R. (2021) Role of Bone-Forming Agents in the Management of Osteoporosis. Aging Clinical and Experimental Research, 33, 775-791. [Google Scholar] [CrossRef] [PubMed]
[27] Hodsman, A.B., Bauer, D.C., Dempster, D.W., Dian, L., Hanley, D.A., Harris, S.T., et al. (2005) Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use. Endocrine Reviews, 26, 688-703. [Google Scholar] [CrossRef] [PubMed]
[28] Kobza, A.O., Papaioannou, A., Lau, A.N. and Adachi, J.D. (2020) Romosozumab in the Treatment of Osteoporosis. Immunotherapy, 12, 965-981. [Google Scholar] [CrossRef] [PubMed]
[29] 林清宇. Apelin-13在NONFH的临床意义及其与虫草素对rBMSCs成骨分化作用的研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2021.
[30] 杨建平. 虫草素对人脂肪干细胞成骨分化作用的实验研究[D]: [博士学位论文]. 南京: 南京医科大学, 2017.
[31] 刘立柱, 李超艺, 林诗炜, 等. 虫草素通过抑制氧化应激和炎症反应对骨折愈合的影响研究[J]. 天津中医药, 2022, 39(3): 380-385.
[32] 夏晨. 光交联透明质酸水凝胶结合包裹虫草素壳聚糖治疗骨关节炎[D]: [硕士学位论文]. 杭州: 浙江大学, 2018.